Chitosan oligosaccharide alleviates renal fibrosis through reducing oxidative stress damage and regulating TGF-β1/Smads pathway

Renal fibrosis (RF) is the common pathway for a variety of chronic kidney diseases that progress to end-stage renal disease. Chitosan oligosaccharide (COS) has been identified as possessing many health functions. However, it is not clear whether COS can prevent RF. The purpose of this paper was to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jun, Xu, Yingtao, Geng, Zikai, Zhou, Jianqing, Xiong, Qingping, Xu, Zhimeng, Li, Hailun, Han, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649626/
https://www.ncbi.nlm.nih.gov/pubmed/36357407
http://dx.doi.org/10.1038/s41598-022-20719-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649626/
https://www.ncbi.nlm.nih.gov/pubmed/36357407
http://dx.doi.org/10.1038/s41598-022-20719-1

Ejemplares similares